Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

GlaxoSmithKline stories

Apr 12, 2026

Two-Antibody Cocktail Developed to Combat Drug-Resistant RSV

Chinese scientists have developed a two-antibody cocktail for respiratory syncytial virus that prevented drug resistance in laboratory studies, addressing a persistent problem in RSV treatment.

Apr 12, 2026·1 source
00

Top claims

  • ▪Respiratory syncytial virus (RSV) is a seasonal infection that circulates globally.
  • ▪Infants are among the most vulnerable to respiratory syncytial virus (RSV).
  • ▪GlaxoSmithKline's Arexvy is a respiratory syncytial virus (RSV) vaccine available for people who are 65 and older.

Related entities

PfizerChina

Featured Stories

OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns

OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns

Aug 7, 2026·2 sources